Burak Durmaz
Overview
Explore the profile of Burak Durmaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Boschann F, Cogulu M, Pehlivan D, Balachandran S, Vallecillo-Garcia P, Grochowski C, et al.
Genet Med
. 2022 Aug;
24(10):2187-2193.
PMID: 35962790
Purpose: We aimed to identify the underlying genetic cause for a novel form of distal arthrogryposis. Methods: Rare variant family-based genomics, exome sequencing, and disease-specific panel sequencing were used to...
12.
Demir D, Hekimgil M, Karaca E, Ulusoy Y, Hekimci Ozdemir H, Saydam G, et al.
J Clin Pathol
. 2022 Aug;
76(4):244-251.
PMID: 35927017
Aim: Myeloid sarcoma (MS) is a rare tumour comprising myeloid blasts occurring at an anatomical site other than the bone marrow. We sought to investigate both paediatric and adult patients...
13.
Arslan Davulcu E, Pekerbas M, Karaca E, Durmaz B, Ozsan N, Akin H, et al.
Cancer Genet
. 2022 Jul;
266-267:74-80.
PMID: 35843036
Chronic myeloid leukemia (CML) is a common hematological malignancy originating from bone marrow stem cells. Chromosomal abnormalities can be seen in almost all cases, the most known anomaly being Philadelphia...
14.
Acet F, Sahin G, Ucar A, Emirdar V, Karaca E, Durmaz B, et al.
J Gynecol Obstet Hum Reprod
. 2022 May;
51(7):102405.
PMID: 35569796
Background: Patients with mosaic Turner syndrome who have normal phenotype and pubertal development may be diagnosed based on karyotype examination which is performed due to recurrent abortion or recurrent implantation...
15.
Kok Kilic G, Pariltay E, Karaca E, Durmaz B, Ekici H, Imamoglu M, et al.
Taiwan J Obstet Gynecol
. 2022 Feb;
61(1):122-126.
PMID: 35181020
Objective: Tetrasomy 9p is a rare fetal condition. Cases are usually mosaic. Here, we present a non-mosaic tetrasomy 9p case with cytogenetic analysis, fluorescence in situ hybridization, microarray data, ultrasound...
16.
Dundar M, Fahrioglu U, Yildiz S, Bakir-Gungor B, Temel S, Akin H, et al.
Funct Integr Genomics
. 2022 Jan;
22(3):291-315.
PMID: 35098403
Familial Mediterranean fever (FMF) is a monogenic autoinflammatory disorder with recurrent fever, abdominal pain, serositis, articular manifestations, erysipelas-like erythema, and renal complications as its main features. Caused by the mutations...
17.
Durmaz B, Bagca B, Cogulu O, Yilmaz Susluer S, Alpay A, Aksoylar S, et al.
Biomed Res Int
. 2021 Dec;
2021:3207328.
PMID: 34877353
Prednisolone has been used frequently in the treatment of acute lymphoblastic leukemia. However, to overcome the challenges of the treatment, the development of additional therapies is of great importance. Small,...
18.
Celik K, Bilim P, Garip G, Durmaz B, Yildirim Sozmen E, Baka M
Int J Dev Neurosci
. 2021 Dec;
82(1):85-95.
PMID: 34850973
Objectives: The present study aimed to investigate the effects of acute hypoxia exposure following prenatal stress on the novelty-seeking behavior and hippocampus of adolescent rats. Methods: The offspring were divided...
19.
Kahraman C, Turgay F, Yigitturk O, Canuzmez A, Durmaz B, Asikovali S
Biol Trace Elem Res
. 2021 Aug;
200(6):2588-2596.
PMID: 34398419
This study investigated the role of TMPRSS6 C > T polymorphism (TMPRP) on the effects of chronic aerobic training on main hematological parameters in male soccer referees, which is yet...
20.
C Yilmaz U, Bagca B, Karaca E, Durmaz A, Durmaz B, Aykut A, et al.
Anticancer Agents Med Chem
. 2021 May;
22(2):378-389.
PMID: 33949939
Background: Grade IV gliomas are classified as glioblastoma (GBM), which is the most malignant brain cancer type. Various genetic and epigenetic mechanisms play a role in the initiation and progression...